Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk

The polypill: An effective approach to increasing adherence and reducing cardiovascular event risk

(2016) Peter Bramlage et al.   European Journal of Preventive Cardiology

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

(2014) V. Selak et al.   BMJ-British Medical Journal

A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk

(2014) Anushka Patel et al.   European Journal of Preventive Cardiology

Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD

(2013) Simon Thom   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study: Table 1

(2013) Satnam K Virdee et al.   BMJ Open

Effect of dosing frequency on chronic cardiovascular disease medication adherence

(2012) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled Trials

(2012) C Raina Elley et al.   PLoS One

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

(2012)   European Journal of Preventive Cardiology

Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe

(2012) Simon Thom et al.   European Journal of Preventive Cardiology

Cardiovascular prevention and international health: time for action

(2011) Joyce L Browne et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

(2011) Salim Yusuf et al.   LANCET

Full Coverage for Preventive Medications after Myocardial Infarction

(2011) Niteesh K. Choudhry et al.   NEW ENGLAND JOURNAL OF MEDICINE

An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk

(2011)   PLoS One

The cardiovascular polypill in high-risk patients

(2011) Melvin Lafeber et al.   European Journal of Preventive Cardiology

Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents

(2009) Ajay K. Gupta et al.   HYPERTENSION

A systematic review and meta-analysis on the therapeutic equivalence of statins

(2009) T.-C. Weng et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET